4//SEC Filing
Mazar Andrew Paul 4
Accession 0001683168-25-002210
CIK 0001652935other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 1:43 PM ET
Size
7.9 KB
Accession
0001683168-25-002210
Insider Transaction Report
Form 4
Mazar Andrew Paul
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-04-01+51,046→ 51,046 totalExercise: $6.70Exp: 2035-03-31→ Common Stock (51,046 underlying) - Award
Employee Stock Option (right to buy)
2025-04-01+110,346→ 110,346 totalExercise: $6.70Exp: 2035-03-31→ Common Stock (110,346 underlying)
Footnotes (2)
- [F1]Options will vest as to 25% on April 1, 2026 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date.
- [F2]Options will vest as to 25% on August 14, 2025 with the remaining 75% vesting in equal monthly installments during the 36 months thereafter.
Documents
Issuer
ACTUATE THERAPEUTICS, INC.
CIK 0001652935
Entity typeother
Related Parties
1- filerCIK 0001727393
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 1:43 PM ET
- Size
- 7.9 KB